Antibiotice S.A. (BVB:ATB)

Romania flag Romania · Delayed Price · Currency is RON
2.130
+0.075 (3.65%)
At close: Feb 27, 2026
-12.35%
Market Cap 1.43B
Revenue (ttm) 648.96M
Net Income (ttm) 56.90M
Shares Out 671.34M
EPS (ttm) 0.08
PE Ratio 25.13
Forward PE n/a
Dividend 0.02 (0.97%)
Ex-Dividend Date Sep 25, 2025
Volume 568,197
Average Volume 524,398
Open 2.100
Previous Close 2.055
Day's Range 2.090 - 2.150
52-Week Range 1.750 - 2.725
Beta 0.19
RSI 35.62
Earnings Date Feb 26, 2026

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d... [Read more]

Industry Pharmaceutical Preparations
Founded 1955
Employees 1,357
Stock Exchange Bucharest Stock Exchange
Ticker Symbol ATB
Full Company Profile

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.

Financial Statements

News

There is no news available yet.